Advantages of the combined therapy with metformin and glimepiride in patients with type 2 diabetes mellitus
Background. The use of glimepiride in the therapy of type 2 diabetes mellitus (DM) fewer stimulates the pancreas, keeping its resource, and does not result in hyperinsulinemia, and also provides the highest profile of safety at the lowest stimulation effect on the secretion of insulin. A research ai...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Zaslavsky O.Yu.
2017-03-01
|
| Edice: | Mìžnarodnij Endokrinologìčnij Žurnal |
| Témata: | |
| On-line přístup: | http://iej.zaslavsky.com.ua/article/view/100598 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|